glp journey retatrutide 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

Spinal duro-mechanical oscillation analysis via M-mode ultrasound may serve as a non-invasive biomarker for diagnosing and monitoring treatment efficacy

Berndt J, Ooi SL, Pak SC

Expression of -glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine

F.WozniakM.et al (2018)

Water: Drink more than you think you need

The terminal half-life was determined based on the terminal slope, which was obtained by converting the micro-constants from the 2-compartment model to macro constants ( 03hr ) was obtained by integrating the curve over this time period, while the total AUC (AUC 0- ) was derived using the dose divided by clearance